228 related articles for article (PubMed ID: 12748494)
1. Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease.
Khanlian SA; Smith HO; Cole LA
Am J Obstet Gynecol; 2003 May; 188(5):1254-9. PubMed ID: 12748494
[TBL] [Abstract][Full Text] [Related]
2. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
3. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
4. Inappropriate management of women with persistent low hCG results.
Cole LA; Khanlian SA
J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
Cole LA; Muller CY
Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
[TBL] [Abstract][Full Text] [Related]
6. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
7. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
Cole LA; Kohorn E; Smith HO
Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
[TBL] [Abstract][Full Text] [Related]
8. What we know about low-level hCG: definition, classification and management.
Kohorn EI
J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
11. Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases.
Cole LA
Int J Gynecol Cancer; 2014 Nov; 24(9):1709-14. PubMed ID: 25275660
[TBL] [Abstract][Full Text] [Related]
12. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
13. [Gestational trophoblastic disease].
Allias F; Bolze PA; Gaillot-Durand L; Devouassoux-Shisheboran M;
Ann Pathol; 2014 Dec; 34(6):434-47. PubMed ID: 25499859
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with persistent low-level elevation of human chorionic gonadotrophin.
Qian XQ; Chen LL; Li BH; Cheng XD; Wan XY
J Obstet Gynaecol Res; 2016 Jun; 42(6):694-700. PubMed ID: 26916449
[TBL] [Abstract][Full Text] [Related]
15. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease.
de Souza JMQ; Braga A; Sanches Dos Santos R; Ramos MM; Cortés-Charry R; Maestá I
Int J Gynecol Cancer; 2017 Sep; 27(7):1494-1500. PubMed ID: 28692637
[TBL] [Abstract][Full Text] [Related]
17. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
[TBL] [Abstract][Full Text] [Related]
18. Advances in the clinical laboratory detection of gestational trophoblastic disease.
Seki K; Matsui H; Sekiya S
Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
[TBL] [Abstract][Full Text] [Related]
19. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
Kohorn EI
Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
[TBL] [Abstract][Full Text] [Related]
20. Quantitative urine hCG and urine pregnancy test in gestational trophoblastic disease patients with low hCG titer.
Lertkhachonsuk R
J Med Assoc Thai; 2015 Jan; 98 Suppl 1():S36-41. PubMed ID: 25764611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]